Chronic Myelomonocytic Leukemia Recruiting Phase 2 Trials for Galiximab (DB04901)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01773395GVAX vs. Placebo for MDS/AML After Allo HSCTTreatment